Even though these data supported the idea of a role of NFKB2 variants in modulating immune responses, we think that additional experiments are still needed to determine whether ACPA or specific haplotypes are factors involved in modulating the effect of the NFKB2 locus on the risk of RA. This evidence concerns the gene NFKB2 and rheumatoid arthritis.